Commission Implementing Regulation (EU) 2022/2314 of 25 November 2022 renewing the approval of the active substance Pythium oligandrum strain M1 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)
Common Name, Identification Numbers | IUPAC Name | Purity | Date of approval | Expiration of approval | Specific provisions |
---|---|---|---|---|---|
Not applicable | No relevant impurities |
|
(1) in Part A, entry 202 on Pythium oligandrum strain M1 is deleted;(2) in Part B, the following entry is added: Further details on the identity and the specification of the active substance are provided in the renewal report." No Common Name, Identification Numbers IUPAC Name Purity Date of approval Expiration of approval Specific provisions " 155 Pythium oligandrum strain M1Culture collection No ATCC 38472 Not applicable No relevant impurities 1 March 2023 28 February 2038 For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on Pythium oligandrum strain M1, and in particular Appendices I and II thereof, shall be taken into account.In this overall assessment Member States shall pay particular attention to: the specification of the technical material as commercially manufactured, the protection of operators and workers, taking into account that microorganisms are per se considered as potential sensitisers and that physical effects on the respiratory system due to the remnants of culture medium and co-formulants in the Microbial Pest Control Product (MPCP) cannot be excluded.
Conditions of use shall include risk mitigation measures, such as: adequate personal protective and respiratory protective equipment for operators using products containing Pythium oligandrum strain M1.
----------------------Further details on the identity and the specification of the active substance are provided in the renewal report."